Abbott Laboratories

120.71+0.9000+0.75%Vol 853.43K1Y Perf 20.78%
Jul 28th, 2021 11:37 DELAYED
BID120.71 ASK120.74
Open119.81 Previous Close119.81
Pre-Market119.78 After-Market-
 -0.03 -0.03%  - -
Target Price
129.71 
Analyst Rating
Strong Buy 1.44
Potential %
7.55 
Finscreener Ranking
★★★     50.42
Insiders Trans % 3/6/12 mo.
-100/-90/-94 
Value Ranking
★★+     49.16
Insiders Value % 3/6/12 mo.
-100/-99/-99 
Growth Ranking
★★★★     61.55
Insiders Shares Cnt. % 3/6/12 mo.
-100/-99/-99 
Income Ranking
★★★     44.64
Market Cap214.48B 
Earnings Rating
Strong Sell
Price Range Ratio 52W %
73.79 
Earnings Date
22nd Jul 2021

Today's Price Range

119.28120.72

52W Range

98.67128.54

5 Year PE Ratio Range

12.30277.50

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
0.70%
1 Month
3.55%
3 Months
-1.35%
6 Months
-0.48%
1 Year
20.78%
3 Years
83.59%
5 Years
169.54%
10 Years
156.68%

TickerPriceChg.Chg.%
ABT120.710.90000.75
AAPL145.49-1.2800-0.87
GOOG2 759.2923.36000.85
MSFT288.121.58000.55
XOM58.140.31000.54
WFC45.430.29000.64
JNJ173.150.49000.28
FB372.474.66001.27
GE13.160.08000.61
JPM151.660.21000.14
Financial StrengthValueIndustryS&P 500US Markets
1.30
1.80
0.34
0.55
14.80
Leverage Ratio 2.20
ProfitabilityValueIndustryS&P 500US Markets
55.70
18.50
27.70
11.90
15.96
RevenueValueIndustryS&P 500US Markets
40.23B
22.64
7.46
12.12
DividendsValueIndustryS&P 500US Markets
1.51
1.80
11.40
8.57
Payout ratio57.00
Earnings HistoryEstimateReportedSurprise %
Q02 20211.011.1715.84
Q01 20211.331.32-0.75
Q04 20201.361.456.62
Q03 20200.900.988.89
Q02 20200.430.5732.56
Q01 20200.550.6518.18
Q04 20190.950.950.00
Q03 20190.840.840.00
Earnings Per EndEstimateRevision %Trend
9/2021 QR0.92-24.59Negative
12/2021 QR1.01-21.09Negative
12/2021 FY4.40-12.87Negative
12/2022 FY4.65-14.84Negative
Next Report Date-
Estimated EPS Next Report1.01
Estimates Count9
EPS Growth Next 5 Years %11.70
Volume Overview
Volume853.43K
Shares Outstanding1.78B
Trades Count11.18K
Dollar Volume637.54M
Avg. Volume5.68M
Avg. Weekly Volume4.60M
Avg. Monthly Volume4.68M
Avg. Quarterly Volume6.23M

Abbott Laboratories (NYSE: ABT) stock closed at 119.81 per share at the end of the most recent trading day (a 0.24% change compared to the prior day closing price) with a volume of 5.63M shares and market capitalization of 214.48B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 109000 people. Abbott Laboratories CEO is Robert B. Ford.

The one-year performance of Abbott Laboratories stock is 20.78%, while year-to-date (YTD) performance is 9.43%. ABT stock has a five-year performance of 169.54%. Its 52-week range is between 98.67 and 128.54, which gives ABT stock a 52-week price range ratio of 73.79%

Abbott Laboratories currently has a PE ratio of 34.00, a price-to-book (PB) ratio of 6.40, a price-to-sale (PS) ratio of 5.28, a price to cashflow ratio of 22.00, a PEG ratio of 2.32, a ROA of 8.79%, a ROC of 12.29% and a ROE of 19.76%. The company’s profit margin is 15.96%, its EBITDA margin is 27.70%, and its revenue ttm is $40.23 Billion , which makes it $22.64 revenue per share.

Of the last four earnings reports from Abbott Laboratories, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $1.01 for the next earnings report. Abbott Laboratories’s next earnings report date is -.

The consensus rating of Wall Street analysts for Abbott Laboratories is Strong Buy (1.44), with a target price of $129.71, which is +7.55% compared to the current price. The earnings rating for Abbott Laboratories stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Abbott Laboratories has a dividend yield of 1.51% with a dividend per share of $1.80 and a payout ratio of 57.00%.

Abbott Laboratories has a Buy technical analysis rating based on Technical Indicators (ADX : 9.52, ATR14 : 1.97, CCI20 : 123.20, Chaikin Money Flow : 0.22, MACD : 1.35, Money Flow Index : 44.22, ROC : 0.06, RSI : 59.72, STOCH (14,3) : 73.56, STOCH RSI : 0.38, UO : 62.15, Williams %R : -26.44), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Abbott Laboratories in the last 12-months were: Andrea F. Wainer (Option Excercise at a value of $1 152 000), Andrea F. Wainer (Sold 40 437 shares of value $4 410 287 ), Charles R. Brynelsen (Sold 1 002 shares of value $120 851 ), Christopher J. Scoggins (Option Excercise at a value of $2 017 200), Christopher J. Scoggins (Sold 45 000 shares of value $5 545 800 ), Daniel Gesua Sive Salvadori (Option Excercise at a value of $1 996 513), Daniel Gesua Sive Salvadori (Sold 44 143 shares of value $4 952 396 ), Gregory A. Ahlberg (Sold 1 052 shares of value $126 882 ), Hubert L. Allen (Option Excercise at a value of $7 887 902), Hubert L. Allen (Sold 203 393 shares of value $25 113 251 ), Jared L. Watkin (Option Excercise at a value of $4 832 629), Jared L. Watkin (Sold 95 967 shares of value $11 507 508 ), John F. Ginascol (Option Excercise at a value of $3 111 584), John F. Ginascol (Sold 352 shares of value $42 455 ), John M. Capek (Option Excercise at a value of $1 413 857), John M. Capek (Sold 52 300 shares of value $5 850 278 ), Joseph J. Manning (Option Excercise at a value of $720 000), Joseph J. Manning (Sold 21 880 shares of value $2 687 347 ), Lisa D. Earnhardt (Sold 943 shares of value $113 735 ), Mary K. Moreland (Sold 905 shares of value $113 621 ), Michael D. Dale (Sold 1 475 shares of value $177 900 ), Michelle A. Kumbier (Buy at a value of $249 900), Phebe N. Novakovic (Option Excercise at a value of $513 431), Phebe N. Novakovic (Sold 4 790 shares of value $513 849 ), Randel W. Woodgrift (Sold 3 534 shares of value $387 911 ), Robert E. Funck (Option Excercise at a value of $10 825 395), Robert E. Funck (Sold 249 999 shares of value $27 206 865 ), Roger M. Bird (Sold 7 403 shares of value $818 168 ), William A. Osborn (Option Excercise at a value of $935 991)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
12 (75.00 %)
12 (75.00 %)
10 (71.43 %)
Moderate Buy
1 (6.25 %)
1 (6.25 %)
1 (7.14 %)
Hold
3 (18.75 %)
3 (18.75 %)
3 (21.43 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.44
Strong Buy
1.44
Strong Buy
1.50

Abbott Laboratories

Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

CEO: Robert B. Ford

Telephone: +1 224 667-6100

Address: 100 Abbott Park Road, Abbott Park 60064-6400, IL, US

Number of employees: 109 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

55%45%

Bearish Bullish

59%41%

News

Stocktwits